Natalia Ramírez

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Ejection Fraction

Top Venues

Life science alliance

Transplant infectious disease : an official journal of the Transplantation Society

Navarrabiomed-Fundación Miguel Servet

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Navarrabiomed-Fundación Miguel Servet Nov 14 2014

Spain

Investigadora Principal :: Grupo de Oncohematología

Navarrabiomed-Fundación Miguel Servet Feb 15 2010 - Nov 13 2014

Spain

Responsable de laboratorio :: Grupo de Oncohematología

Centro de Investigación Médica Aplicada, Universidad de Navarra Oct 01 2005 - Oct 01 2009

Spain

Investigadora Postdoctoral :: Laboratorio de Farmacogenómica

Clinica Universitaria de Navarra Jul 01 2000 - Feb 28 2005

Spain

Investigadora Predoctoral :: Servicio de Inmunología

Publications

Rubén Gil-Bescós, Ainhoa Ostiz, Saioa Zalba, Ibai Tamayo, Eva Bandres, Elvira Rojas-de-Miguel, Margarita Redondo, Amaya Zabalza, Natalia Ramírez
Potency assessment of IFNγ-producing SARS-CoV-2-specific T cells from COVID-19 convalescent subjects. Life science alliance 6 (6) (2023)
Rubén Gil-Bescós, Ainhoa Ostiz, Saioa Zalba, Ibai Tamayo, Eva Bandres, Elvira Rojas-de-Miguel, Margarita Redondo, Amaya Zabalza, Natalia Ramírez
Potency assessment of IFNγ-producing SARS-CoV-2-specific T cells from COVID-19 convalescent subjects. Life science alliance 6 (6) (2023)
Rubén Gil-Bescós, Ainhoa Ostiz, Saioa Zalba, Ibai Tamayo, Eva Bandres, Elvira Rojas-de-Miguel, Margarita Redondo, Amaya Zabalza, Natalia Ramírez
Potency assessment of IFNγ-producing SARS-CoV-2-specific T cells from COVID-19 convalescent subjects. Life science alliance 6 (6) (2023)
Miriam Ciáurriz, Lorea Beloki, Amaya Zabalza, Eva Bandrés, Cristina Mansilla, Estela Pérez-Valderrama, Mercedes Lachén, Mercedes Rodríguez-Calvillo, Natalia Ramírez, Eduardo Olavarría
Functional specific-T-cell expansion after first cytomegalovirus reactivation predicts viremia control in allogeneic hematopoietic stem cell transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society 19 (6) (2017)